PETALING JAYA: It is only the new enrollment of patients for hydroxychloroquine treatment under the Covid-19 global trial that has been temporarily suspended, says the World Health Organisation (WHO) representative to Malaysia.
Dr Jacqueline Lo Ying-Ru, Head of Mission and WHO representative to Malaysia, Brunei and Singapore, clarified that patients who had previously enrolled under the trial would finish their hydroxychloroquine treatment.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
